Project Grant R21AI178535

Award Date 6/6/24
Completion Date 4/30/26
Dollars Obligated $784K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
This federal Project Grant award of $699,814 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand the molecular mechanisms of malaria parasite-mosquito midgut interactions and develop new transmission-blocking approaches. The key objectives are to functionally characterize mosquito and parasite proteins that mediate these interactions, evaluate their potential as...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $700,288 to the University of South Florida (USF) to conduct research aimed at identifying genetic factors associated with gametocyte development in Plasmodium falciparum, the parasite that causes malaria. The research project leverages USF's expertise in gametocyte biology, computational genomics, and...
This $648,924 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate the role of mosquito extracellular vesicles (EVs) in immune function and malaria parasite killing. The key objectives are to: 1) define the mechanisms by which mosquito EVs promote Plasmodium ookinete recognition and complement-mediated killing, and 2) elucidate the role of EVs in...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $211,038 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Johns Hopkins University to target a reductive dehalogenase enzyme as a new strategy for controlling mosquito populations. The research aims to investigate how this enzyme protects insects like fruit flies and mosquitoes from the accumulation of endogenous halotyrosines, which can suppress fertility. The project will examine the role...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $3,762,999.00 to the Institute for Systems Biology (ISB) in Seattle, WA to conduct research on the immunogenic landscape of early mosquito-stage Plasmodium falciparum parasites. The goal is to accelerate the discovery of transmission-blocking vaccine candidates for malaria. The research will utilize mass...
This $606,815 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to Duquesne University aims to engineer paratransgenic bacterial strains that can interfere with the ability of mosquitoes to transmit malaria parasites. Specifically, the project will leverage expertise in bacterial genetics and vector microbial ecology to develop paratransgenic strains of Asaia bogorensis that have no antibiotic...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $832,071 Project Grant (CFDA 93.855) to Seattle Children's Hospital to conduct research aimed at developing a universal malaria transmission-blocking vaccine. The research program combines expertise in antigen and monoclonal antibody technologies, malaria vector stage biology, and structure-guided vaccinology. Key objectives include: Developing potent transmission-reducing monoclonal antibodies with...
This $676,425 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate the mechanisms by which the Plasmodium falciparum parasite causes neutrophil dysfunction during malaria infection. The research team at The Washington University aims to identify how the parasite's secreted histidine-rich protein II (HRPII) impairs the oxidative burst activity of neutrophils, a...
This Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $702,204 to the London School of Hygiene and Tropical Medicine (LSHTM) to conduct research on complex malaria in India. The key products and services to be delivered include: A four-year community-based cohort study in three districts of Odisha, India to investigate factors supporting persistent malaria...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $102,600 to the College of Health Sciences at the University of Ghana. The award supports research to compare sampling methods for the invasive Anopheles stephensi mosquito species and other native malaria vectors in Ghana, as well as determine the extent of spread and population dynamics of An. stephensi in sentinel...

INVESTIGATING THE MECHANISMS UNDERLYING MOSQUITO INFECTIOUSNESS IN MALARIA - PROJECT SUMMARY MALARIA CONTINUES TO HAVE A HUGE TOLL ON MORBIDITY AND MORTALITY IN THE WORLD, RESPONSIBLE FOR OVER 600,000 DEATHS ANNUALLY. THE TRANSMISSION STAGES ARE BOTTLENECKS FOR THE PARASITE AND THUS CRITICAL STAGES FOR INTERVENTION, PARTICULARLY WHEN AIMING FOR ELIMINATION. USING THE RODENT MODEL PLASMODIUM YOELLI, WE RECENTLY FOUND THAT SALIVARY GLAND SPOROZOITE LOAD OF A BITING MOSQUITO STRONGLY CORRELATES WITH INFECTION LIKELIHOOD, WITH HIGHLY INFECTED MOSQUITOES BEING 7.5 TIMES MORE LIKELY TO INITIATE AN INFECTION. IMPORTANTLY, THE LIKELIHOOD OF ACHIEVING SECONDARY INFECTIONS RAPIDLY RISES AT SALIVARY GLAND SPOROZOITE DENSITIES >10,000 THAT REPRESENT A SMALL PROPORTION OF FIELD- CAUGHT MOSQUITOES. THESE DATA CHALLENGE THE ASSUMPTION THAT ALL INFECTED MOSQUITOES ARE EQUAL, A BELIEF THAT UNDERLIES EPIDEMIOLOGICAL MODELS OF TRANSMISSION AND IMPACTS MALARIA ELIMINATION STRATEGIES. IN THIS PROPOSAL WE WILL DETERMINE THE MECHANISMS UNDERLYING THE INCREASED INFECTIOUS POTENTIAL OF HIGHLY INFECTED MOSQUITOES, COMPARING THE QUANTITY OF SPOROZOITES INOCULATED BY MOSQUITOES HARBORING HIGH AND LOW NUMBERS OF SPOROZOITES, AS WELL AS THE QUALITY OF SPOROZOITES IN THESE TWO GROUPS. IN AIM 1 WE WILL DETERMINE THE INOCULA ASSOCIATED WITH LOW- AND HIGH-INFECTED MOSQUITOES USING BOTH RODENT MALARIA PARASITES AND THE HUMAN PARASITE P. FALCIPARUM. IN AIM 2, WE WILL COMPARE SPOROZOITES FROM MOSQUITOES WITH LOW AND HIGH INFECTIONS USING INFECTION ASSAYS, INTRAVITAL IMAGING, AND SINGLE-CELL RNA-SEQ ANALYSIS. OVERALL THESE EXPERIMENTS WILL FILL CRUCIAL KNOWLEDGE GAPS ON PARASITE TRANSMISSION PROBABILITY THAT WILL GREATLY IMPROVE OUR UNDERSTANDING OF PARASITE BIOLOGY AND EPIDEMIOLOGY.

Posted 6/6/24, 12:00 AM